Women with breast cancer are 10 per cent more likely to survive for five years or more if they have certain immune cells near their tumour, according to research published in Annals of Oncology today.
Jun 10, 2014
0
0
Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer ...
Jun 25, 2014
0
0
There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in ...
Oct 22, 2018
0
0
(HealthDay)—A novel deep learning model (DeepGrade [DG]) improves prognostic stratification for Nottingham histologic grade 2 (NHG 2) breast tumors, according to a study published online Sept. 29 in the Annals of Oncology.
Oct 4, 2021
0
0
Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk of long-term side-effects, a new study reports. As many as 96% of men ...
Aug 16, 2013
0
0
Researchers predict that death rates from cancer will fall in 2018 in Australasian countries and in Russia. However, a greater proportion of the population will die in Russia from the disease than in any of the other countries, ...
Dec 10, 2018
0
1
A large prospective study of COVID-19 outcomes in people with a history of cancer has found that hospital mortality rates do not appear to have reduced over time, unlike those for people with no history of cancer.
Sep 22, 2021
0
6
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in progression-free survival (PFS) in newly diagnosed patients with advanced ...
Oct 22, 2018
0
0
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology. The publication is for 'Arm Q,' which is ...
Jan 7, 2020
0
2
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
Mar 22, 2021
0
6
